ResearcherCalifornia University of Science and MedicineNo recent work listed

Maiyon Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0784-5594; OpenAlex author ID A5039497404. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed through NLS-mediated signaling activities Co-author DOI 10.21203/rs.3.rs-3702688/v1 ↗
Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway. Co-author DOI 10.1186/s12906-018-2139-3 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Devin Sakamoto · 1 shared paper, 2023 · strength 0.22
- Paper Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed t… DOI 10.21203/rs.3.rs-3702688/v1 ↗
Tiantian Qin · 1 shared paper, 2023 · strength 0.22
- Paper Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed t… DOI 10.21203/rs.3.rs-3702688/v1 ↗
Derek Perkins · 1 shared paper, 2018 · strength 0.09
- Paper Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 si… DOI 10.1186/s12906-018-2139-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.